Анджела Маас - Женское сердце. Современный подход к здоровью женщин

Rossouw J. E., Anderson G. L., Prentice R. L. et al. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial // JAMA, 2002. — № 288 (3). — P. 321–333.

Neves ECNM, Birkhauser M., Samsioe G. et al. EMAS position statement: the ten point guide to the integral management of menopausal health // Maturitas, 2015. — № 81 (1). — P. 88–92.

Mintziori G., Lambrinoudaki I., Goulis D. G. et al. EMAS position statement: non-hormonal management of menopausal vasomotor symptoms // Maturitas, 2015. — № 81 (3). — P. 410–413.

Canoy D., Beral V., Balkwill A. et al. Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort // Circulation, 2015. — № 131. — P. 237–244.

He C., Murabito J. M. Genome-wide association studies of age at menarche and age at natural menopause // Mol Cell Endocrinol, 2014. — № 382 (1). — P. 767–779.

Mu F., Rich-Edwards J., Rimm E. B. et al. Endometriosis and risk of coronary heart disease // Circ Cardiovasc Qual Outcomes, 2016. — № 9 (3). — P. 257–264.

Fauser BCJM, Tarlatzis B. C., Rebar R. W. et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group // Fertil Steril, 2012. — № 97. — P. 28–38.

Heida K. Y., Bots M. L., de Groot C. J. M. et al. Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline // Eur J Prev Cardiol, 2016. — № 23 (17). — P. 1863–1879.

Ingelsson E., Lundholm C., Johansson A. L. et al. Hysterectomy and risk of cardiovascular disease: a population-based cohort study // Eur Heart J, 2011. — № 32 (6). — P. 745–750.

Kurth T., Winter A. C., Eliassen A. H. et al. Migraine and risk of cardiovascular disease in women: prospective cohort study // BMJ, 2016. — № 353. — i2610.

Van Hemert S., Breedveld A. C., Rovers J. M. et al. Migraine associated with gastrointestinal disorders: review of the literature and clinical implications // Front Neurol, 2014. — № 5. — P. 241.

Ranthe M. F., Diaz L. J., Behrens I. et al. Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study // Eur Heart J, 2016. — № 37 (11). — P. 900–907.

Auger N., Fraser W. D., Healy-Profitós J., Arbour L. Association between preeclampsia and congenital heart defects // JAMA, 2015. — № 314 (15). — P. 1588–1598.

Zoet G. A., Benschop L., Boersma E. et al. Prevalence of subclinical coronary artery disease assessed by coronary computed tomography angiography in 45- to 55-year-old women with a history of preeclampsia // Circulation, 2018. — № 137 (8). — P. 877–879.

Aukes A. M., De Groot J. C., Wiegman M. J. et al. Long-term cerebral imaging after preeclampsia // BJOG, 2012 (Aug). — № 119 (9). — P. 1117–1122.

Heida K. Y., Franx A., van Rijn B. B. et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus // Hypertension, 2015. — № 66 (6). — P. 1116–1122.

Elias-Smale S. E., Günal A., Maas A. H. Gynecardiology: Distinct patterns of ischemic heart disease in middle-aged women // Maturitas, 2015. — № 81 (3). — P. 348–352.

Mason J. C., Libby P. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions // Eur Heart J, 2015. — № 36 (8). — P. 482–9c.

Bano A., Dhana K., Chaker L. et al. Association of thyroid function with life expectancy with and without cardiovascular disease: The Rotterdam Study // JAMA Intern Med, 2017. — № 177 (11). — P. 1650–1657.

Parikh N. I., Jeppson R. P., Berger J. S. et al. Reproductive risk factors and coronary heart disease in the Women’s Health Initiative Observational study // Circulation, 2016. — № 133 (22). — P. 2149–2158.

Tuzcu E. M., Kapadia S. R., Tutar E. et al. High Prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound // Circulation, 2001. — № 103. — P. 2705–2710.

Claudio C. P., Quesada O., Pepine C. J., Bairey Merz C. N. Why names matter for women: MINOCA/INOCA (Myocardial infarction/ ischemia and no obstructive coronary artery disease) // Clinical Cardiology, 2018. — № 41. — P. 185–193.

Johnston N., Schenck-Gustafsson K., Lagerqvist B. Are we using cardiovascular medications and coronary angiography appropriately in men and women with chest pain? // Eur Heart J, 2011. — № 32 (11). — P. 1331–1336.

Jespersen L., Hvelplund A., Abildstrom S. Z. et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events // Eur Heart J, 2012. — № 33 (6). — P. 734–744.

Sedlak T. L., Lee M., Izadnegahdar M. et al. Sex differences in clinical outcomes in patients with stable angina and no obstructive obstructive coronary artery disease // Am Heart J, 2013. — № 166 (1). — P. 38–44.

Gulati M., Cooper-DeHoff R. M., McClure C. et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women’s Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project // Arch Intern Med, 2009. — № 169 (9). — P. 843–850.

Kreatsoulas C., Shannon H. S., Giacomini M. et al. Reconstructing angina: cardiac symptoms are the same in women and men // JAMA Intern Med, 2013. — № 173 (9). — P. 829–831.

Pagidipati N. J., Hemal K., Coles A. et al. Sex differences in functional and CT angiography testing in patients with suspected coronary artery disease // J Am Coll Cardiol, 2016. — № 67 (22). — P. 2607–2616.

Ong P., Camici P. G., Beltrame J. F. et al. International standardization of diagnostic criteria for microvascular angina // Int J Cardiol, 2018. — № 250. — P. 16–20.

Camici P. G., Crea F. Coronary microvascular dysfunction // N Engl J Med, 2007. — № 356 (8). — P. 830–840.

Taqueti V. R., Solomon S. D., Shah A. M. et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction // Eur Heart J, 2018. — № 39. — P. 840–849.

Konst R. E., Elias-Smale S. E., Lier A. et al. Different cardiovascular risk factors and psychosocial burden in symptomatic women with and without obstructive coronary artery disease // Eur J Prev Cardiol, 2019. — № 26 (6). — P. 657–659.